Hyperfine (NASDAQ:HYPR) and 908 Devices (NASDAQ:MASS) Critical Contrast

Hyperfine (NASDAQ:HYPR) and 908 Devices (NASDAQ:MASS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.

Risk & Volatility

Hyperfine has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.63, indicating that its share price is 37% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and price targets for Hyperfine and 908 Devices, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	1	2	3	0	2.33
908 Devices	1	0	1	0	2.00

Hyperfine presently has a consensus target price of $1.78, suggesting a potential upside of 11.46%. 908 Devices has a consensus target price of $12.00, suggesting a potential upside of 35.75%. Given 908 Devices’ higher possible upside, analysts clearly believe 908 Devices is more favorable than Hyperfine.

Profitability

This table compares Hyperfine and 908 Devices’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hyperfine	-226.88%	-98.83%	-67.09%
908 Devices	-62.40%	-14.03%	-10.40%

Insider and Institutional Ownership

15.0% of Hyperfine shares are held by institutional investors. Comparatively, 88.1% of 908 Devices shares are held by institutional investors. 26.3% of Hyperfine shares are held by company insiders. Comparatively, 28.2% of 908 Devices shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Hyperfine and 908 Devices”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$11.40 million	13.93	-$35.57 million	($0.41)	-3.90
908 Devices	$56.20 million	5.95	$19.49 million	($1.00)	-8.84

908 Devices has higher revenue and earnings than Hyperfine. 908 Devices is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

Summary

908 Devices beats Hyperfine on 8 of the 14 factors compared between the two stocks.

About Hyperfine

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

About 908 Devices

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.